161 related articles for article (PubMed ID: 19191587)
1. Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.
Han M; Gillard BK; Courtney HS; Ward K; Rosales C; Khant H; Ludtke SJ; Pownall HJ
Biochemistry; 2009 Feb; 48(7):1481-7. PubMed ID: 19191587
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
[TBL] [Abstract][Full Text] [Related]
3. Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.
Gillard BK; Courtney HS; Massey JB; Pownall HJ
Biochemistry; 2007 Nov; 46(45):12968-78. PubMed ID: 17941651
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.
Rosales C; Patel N; Gillard BK; Yelamanchili D; Yang Y; Courtney HS; Santos RD; Gotto AM; Pownall HJ
Biochemistry; 2015 Apr; 54(14):2295-302. PubMed ID: 25790332
[TBL] [Abstract][Full Text] [Related]
5. Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure.
Courtney HS; Zhang YM; Frank MW; Rock CO
J Biol Chem; 2006 Mar; 281(9):5515-21. PubMed ID: 16407233
[TBL] [Abstract][Full Text] [Related]
6. Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.
Gillard BK; Rosales C; Pillai BK; Lin HY; Courtney HS; Pownall HJ
Biochemistry; 2010 Nov; 49(45):9866-73. PubMed ID: 20879789
[TBL] [Abstract][Full Text] [Related]
7. Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.
Pownall HJ; Courtney HS; Gillard BK; Massey JB
Chem Phys Lipids; 2008 Nov; 156(1-2):45-51. PubMed ID: 18838065
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
Rosales C; Tang D; Gillard BK; Courtney HS; Pownall HJ
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1834-41. PubMed ID: 21597008
[TBL] [Abstract][Full Text] [Related]
9. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
[TBL] [Abstract][Full Text] [Related]
10. Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.
Tchoua U; Rosales C; Tang D; Gillard BK; Vaughan A; Lin HY; Courtney HS; Pownall HJ
Lipids; 2010 Dec; 45(12):1117-26. PubMed ID: 20972840
[TBL] [Abstract][Full Text] [Related]
11. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.
Lagrost L; Perségol L; Lallemant C; Gambert P
J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353
[TBL] [Abstract][Full Text] [Related]
12. Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo.
Yang Y; Rosales C; Gillard BK; Gotto AM; Pownall HJ
Biochim Biophys Acta; 2016 Nov; 1861(11):1787-1795. PubMed ID: 27594697
[TBL] [Abstract][Full Text] [Related]
13. Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.
Gillard BK; Rodriguez PJ; Fields DW; Raya JL; Lagor WR; Rosales C; Courtney HS; Gotto AM; Pownall HJ
Biochim Biophys Acta; 2016 Mar; 1861(3):196-204. PubMed ID: 26709142
[TBL] [Abstract][Full Text] [Related]
14. Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies.
Ritter MC; Scanus AM
J Biol Chem; 1977 Feb; 252(4):1208-16. PubMed ID: 190223
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins.
Bruce C; Davidson WS; Kussie P; Lund-Katz S; Phillips MC; Ghosh R; Tall AR
J Biol Chem; 1995 May; 270(19):11532-42. PubMed ID: 7744792
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL.
Groenewegen WA; Averna MR; Pulai J; Krul ES; Schonfeld G
J Lipid Res; 1994 Jun; 35(6):1012-25. PubMed ID: 8077841
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo interactions of Triton 1339 with plasma lipoproteins of normolipidemic rhesus monkeys. Preferential effects on high density lipoproteins.
Yamamoto K; Shen B; Zarins C; Scanu AM
Arteriosclerosis; 1984; 4(4):418-34. PubMed ID: 6431955
[TBL] [Abstract][Full Text] [Related]
18. Remodeling of human plasma lipoproteins by detergent perturbation.
Pownall HJ
Biochemistry; 2005 Jul; 44(28):9714-22. PubMed ID: 16008356
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II.
Rye KA; Garrety KH; Barter PJ
Biochim Biophys Acta; 1993 Apr; 1167(3):316-25. PubMed ID: 8481394
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Groener JE; van Gent T; van Tol A
Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
